Fosun Pharmaceutical: Launch of new "ABC" nucleic acid three-in-one detection product.

On August 28th, Fosun Pharma announced that its independently developed novel coronavirus 2019-nCoV and influenza A/B virus nucleic acid detection kit has officially obtained approval from the National Medical Products Administration for listing. This product is the first approved product under Fosun's diagnostic respiratory infection syndrome multi-target nucleic acid testing program.